Abiopharma

🔍 Bichara Guillermo (Executive)

Company: LINDE PLC (LIN)

Report Date: 2026-03-10

Detailed Transactions and Holdings:

• Sold 4,357 shares of Ordinary Shares at $480.79 per share (Direct)
  Date: 2026-03-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 22,137.77 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-03-10 | Code: H | nature_of_ownership: 401(k) | shares_owned_after: 2,944.98
• Holds 1,830 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-10 | Code: H | shares_owned_after: 1,830.00 | Footnotes: F2, F3, F3
• Holds 1,570 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-10 | Code: H | shares_owned_after: 1,570.00 | Footnotes: F2, F4, F4
• Holds 1,613 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-10 | Code: H | shares_owned_after: 1,613.00 | Footnotes: F2, F5, F5
• Holds 14,917 shares of Stock Options (right to buy) at $483.62 per share (Derivative)
  Date: 2026-03-10 | Code: H | Expires: 2036-03-09 | shares_owned_after: 14,917.00 | Footnotes: F6
• Holds 11,326 shares of Stock Options (right to buy) at $468.77 per share (Derivative)
  Date: 2026-03-10 | Code: H | Expires: 2035-03-07 | shares_owned_after: 11,326.00 | Footnotes: F7
• Holds 10,345 shares of Stock Options (right to buy) at $465.29 per share (Derivative)
  Date: 2026-03-10 | Code: H | Expires: 2034-03-07 | shares_owned_after: 10,345.00 | Footnotes: F8
• Holds 11,085 shares of Stock Options (right to buy) at $354.14 per share (Derivative)
  Date: 2026-03-10 | Code: H | Expires: 2033-03-07 | shares_owned_after: 11,085.00 | Footnotes: F9
• Holds 13,280 shares of Stock Options (right to buy) at $270.99 per share (Derivative)
  Date: 2026-03-10 | Code: H | Expires: 2032-03-07 | shares_owned_after: 13,280.00 | Footnotes: F10
• Holds 20,975 shares of Stock Options (right to buy) at $253.68 per share (Derivative)
  Date: 2026-03-10 | Code: H | Expires: 2031-03-08 | shares_owned_after: 20,975.00 | Footnotes: F11
• Holds 26,155 shares of Stock Options (right to buy) at $173.13 per share (Derivative)
  Date: 2026-03-10 | Code: H | Expires: 2030-03-09 | shares_owned_after: 26,155.00 | Footnotes: F12
• Holds 853 shares of Deferred Stock Units (Derivative)
  Date: 2026-03-10 | Code: H | shares_owned_after: 852.65 | Footnotes: F2, F13, F13

Footnotes:

• F1: Sales made under a 10b5-1 plan entered into on August 22, 2025.
• F2: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
• F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.
• F4: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
• F5: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
• F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.
• F7: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
• F8: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
• F9: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
• F10: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
• F11: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
• F12: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
• F13: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.